Home / Research / Clearances / K143726 Public FDA record
K143726: XLR8 PLUS (XLR8+) 510(k) clearance K143726 for Genadyne Biotechnologies, Inc.. View source facts, labeled dates, and the original FDA record.
FDA identifier K143726
Company in FDA record Genadyne Biotechnologies, Inc.
FDA decision date Jun 19, 2015
First observed by MedTech Watch Nov 16, 2026
Latest observed content change Nov 17, 2026 Decision stated in the source Substantially Equivalent Source facts
Decision Substantially Equivalent
Received 2014-12-29
Specialty General, Plastic Surgery
Decision code SESE
Clearance type Traditional Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Keep following this market Carry a company or product code into your watchlist for ongoing matching and a weekly brief.
Genadyne Biotechnologies, Inc.
14 days free. No card required. Then $49/month when you choose to subscribe.
Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗